Cell Signaling Technology Inc. / Wang L. P. / Thomson / Ge / Proc Natl Acad Sci U S A / Teschendorff A. E. / StemCell Technologies / Molecular Biology Inc. / Santa Cruz Biotechnology Inc. / BD Biosciences / Panula S. P. / Shimizu / Corning / /
Country
Scotland / /
Currency
pence / / /
Facility
University of South / Research Institute / Morsani College of Medicine / SAS Institute / /
IndustryTerm
p53 binding site / transcriptional starting site / statistical software / /
MedicalCondition
ovarian cancers / gastric cancer / ovarian cancer / ovarian cancer stem cell / human solid tumors / wild type p53 tumor / metastasis / J Cancer / aggressive human tumors / melanoma / wild type p53 ovarian cancer / high metastatic tumors / prostate cancer / ovarian cancer stem cells / human breast cancer / breast cancer / human ovarian cancer / ovarian carcinoma / breast tumours / tumor / breast cancers / cancer / human epithelial cancers / serous ovarian cancers / cervical cancer / carcinogenesis / human pancreatic cancer tumor / panel ovarian cancer / malignant melanoma / viral infections / Nat Rev Cancer / high grade tumors / ALDH1 positive ovarian cancer / cancer stem cell / /
MedicalTreatment
chemotherapy / /
Organization
University of South Florida / Department of Pathology / SAS Institute / Research Institute / Morsani College of Medicine / H. Lee Moffitt Cancer Center / American Society for Biochemistry / China Fellowship Council / /
Person
Carey / V / H. Lee Moffitt / Lee Moffitt / Donnell / /
Position
reporter / /
Product
cisplatin / LG 200C Cellular Phone / T-80 / /
ProvinceOrState
Aurora / British Columbia / Rhode Island / M. B. / North Carolina / /
Microsoft Word - miR-214 regulates 0OCSC by targeting p53-Nanog1.doc